|
|
 |
2010 Series : November 30, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To see views enlarged, click on the individual pictures...
| This Caucasian female has no complaints and presents for her yearly eye exam. Best corrected visual acuity is 20/20 in each eye. She has a non-inflamed eye with the gray translucent areas seen in the images. She first noticed the lesions after her cataract extraction which was performed in 2006. The lesions have remained stable in size and have never bothered her. |
| 1. |
The gray translucent areas are located in the: |
|
| a. |
conjunctiva |
| b. |
sclera |
| c. |
episclera |
| d. |
uvea |
| e. |
retina |
|
| 2. |
The gray translucent areas are associated with the: |
|
| a. |
insertion of the horizontal recti |
| b. |
malignant melanoma of the uvea |
| c. |
malignant melanoma of the conjunctiva |
| d. |
post inflammatory thinning of the sclera |
| e. |
none of the above |
|
| 3. |
The diagnosis is: |
|
| a. |
scleritis |
| b. |
malignant melanoma |
| c. |
post scleritis scleral thinning |
| d. |
scleral plaque |
| e. |
none of the above |
|
| 4. |
The gray translucent areas occur in what age patient? |
|
| a. |
10 years old |
| b. |
30 years old |
| c. |
40 years old |
| d. |
50 years old |
| e. |
70 years old |
|
| 5. |
Management should be: |
|
| a. |
topical corticosteroid |
| b. |
topical antibiotic |
| c. |
oral corticosteroid |
| d. |
topical and oral non-steroidal anti-inflammatory medications |
| e. |
observation |
|
For answers to the above, click here on or after December 7, 2010.
|